Accesibilidad a la farmacoterapia específica de la enfermedad de Parkinson, en Santiago de Chile / Accessibility of patients with Parkinson disease to specific pharmacotherapy in Chile
Rev. méd. Chile
; 126(11): 1355-61, nov. 1998. tab
Article
em Es
| LILACS
| ID: lil-243728
Biblioteca responsável:
CL1.1
ABSTRACT
Background:
The high costs of adequate pharmacological treatment for Parkinson disease preclude the universal access of patients to this medication.Aim:
To assess the accessibility to pharmacological treatment of Chilean patients with Parkinson disease. Patients andmethods:
An inquiry about socioeconomic stratification, medical controls, disease features and costs of pharmacological therapy, was applied to 95 patients (56 male, aged 32 to 89 years old) attending the Chilean League Against Parkinson Disease.Results:
Among studied patients, the disease had a mean duration of 7.9ñ6 years. There was a direct relationship between family income, the frequency of visits to physicians and the dose and cost of pharmacological therapy.Conclusions:
The accessibility to pharmacological therapy among patients with Parkinson disease, depends on their socioeconomic level. Measures to correct this situation and improve the quality of life of these patients should be undertaken by health services
Buscar no Google
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Doença de Parkinson
/
Antiparkinsonianos
Aspecto:
Patient_preference
Limite:
Adult
/
Female
/
Humans
/
Male
País/Região como assunto:
America do sul
/
Chile
Idioma:
Es
Revista:
Rev. méd. Chile
Assunto da revista:
MEDICINA
Ano de publicação:
1998
Tipo de documento:
Article
País de publicação:
Chile